MedPath

Shanghai Eye Disease Prevention and Treatment Center

🇨🇳China
Ownership
Private
Employees
-
Market Cap
-
Website

The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow

Not Applicable
Recruiting
Conditions
Myopia
Interventions
Device: Shorter-wavelength dominant light
Device: Light similar to the solar spectrum proportion
Device: Longer-wavelength dominant light
First Posted Date
2022-10-26
Last Posted Date
2022-10-26
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
75
Registration Number
NCT05594719
Locations
🇨🇳

Xiangui He, Shanghai, Shanghai, China

🇨🇳

Shanghai Eye Disease Prevention and Treatment Center, Shanghai, Shanghai, China

Repeated Low-Level Red-Light Therapy for Shortening Axial Length

Not Applicable
Active, not recruiting
Conditions
Refractive Errors
Eye Diseases
High Myopia
Interventions
Device: RLRL
First Posted Date
2022-09-22
Last Posted Date
2024-11-05
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
30
Registration Number
NCT05550740
Locations
🇨🇳

Shanghai Eye Disease Prevention and Treatment Center, Shanghai, Shanghai, China

A Study on the Efficacy and Safety of Multi-focal Scleral Contact Lens

Not Applicable
Not yet recruiting
Conditions
High Myopia
Interventions
Device: Rigid gas permeable contact lens
Device: Multi-focal rigid scleral contact lens
First Posted Date
2022-09-09
Last Posted Date
2022-10-19
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
150
Registration Number
NCT05533450
Locations
🇨🇳

Shanghai Eye Disease Prevention & Treatment Center, Shanghai, Shanghai, China

🇨🇳

Shanghai Eye Disease Prevention and Treatment Center, Shanghai, Shanghai, China

Efficacy and Safety of Defocusing Frame Glasses With Artificial Intelligence in Controlling Myopia Progression

Not Applicable
Recruiting
Conditions
Myopia
Interventions
Device: AI defocusing frame glasses
First Posted Date
2022-09-08
Last Posted Date
2022-10-04
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
138
Registration Number
NCT05532774
Locations
🇨🇳

Shanghai Eye Diseases Prevention & Treatment Center, Shanghai, Shanghai, China

Efficacy and Safety of 1% Atropine "5+3" Regimen in Children and Adolescents Controlling Myopia

Phase 4
Recruiting
Conditions
Myopia
Interventions
First Posted Date
2022-07-08
Last Posted Date
2022-07-12
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
192
Registration Number
NCT05448989
Locations
🇨🇳

Shanghai Eye Diseases Prevention & Treatment Center, Shanghai, Shanghai, China

Study on the Effect of Two Ways of Cycloplegia on Biological Parameters of Ciliary Muscle

Phase 4
Recruiting
Conditions
Refractive Errors
Myopia
Accomodation
Cycloplegia
Interventions
First Posted Date
2022-07-08
Last Posted Date
2023-01-04
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
144
Registration Number
NCT05449015
Locations
🇨🇳

Shanghai Eye Diseases Prevention & Treatment Center, Shanghai, Shanghai, China

Myopia Intervention in Children and Adolescents and Establishment of a Precise Intervention Model

Phase 4
Conditions
Myopia
Interventions
First Posted Date
2022-05-02
Last Posted Date
2022-05-02
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
186
Registration Number
NCT05357326
Locations
🇨🇳

Jianfeng Zhu, Shanghai, Shanghai, China

Red Light Intervention on Myopic Progression

Not Applicable
Conditions
Myopia
Interventions
Device: Red Light Intervention
Drug: Atropine
First Posted Date
2022-01-24
Last Posted Date
2022-10-12
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
104
Registration Number
NCT05203432
Locations
🇨🇳

Shanghai Eye Disease Prevention and Treatment Center, Shanghai, China

The Effectiveness and Safety of Low-intensity Single-wavelength Red Light in Controlling High Myopia in Children and Adolescents:A Randomized, Controlled, Multicenter Clinical Trial

Not Applicable
Completed
Conditions
Age 3 to 16 Years (Inclusive), Male or Female
The Guardian Voluntarily Signed the Subject's Informed Consent Form
Clinical Diagnosis Confirming That Myopia Has Occurred in at Least One Eye
Interventions
Other: Eyesing Redlight Instrument
First Posted Date
2022-01-11
Last Posted Date
2023-11-18
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
192
Registration Number
NCT05184621
Locations
🇨🇳

Shanghai Eye Disease Prevention & Treatment Center, Shanghai, Shanghai, China

Red Light Intervention for Myopia Prevention

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: LLLT(Low Level Laser Therapy)
First Posted Date
2021-04-01
Last Posted Date
2022-09-30
Lead Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Target Recruit Count
278
Registration Number
NCT04825769
Locations
🇨🇳

Xiangui He, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath